{
  "Variants Include": [
    {
      "Gene": "TP53",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.248G>A (p.G83D), causing a structural change affecting protein function."
        },
        {
          "HGVS": "NM_001126112.3:c.251A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "251"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "M",
            "position": "84"
          },
          "Description in input context": "c.251A>T (p.I84M) shows altered stability under stress conditions."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Hereditary Myopathy",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Experiments were conducted using the HEK293 cell line, transfected with wild-type and mutant TP53 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression was reduced by 50% for the variant NM_001126112.3:c.248G>A, and showed increased degradation."
        },
        {
          "Variant": "NM_001126112.3:c.251A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered stability",
          "Result Description": "The variant NM_001126112.3:c.251A>T exhibited increased instability under oxidative stress conditions compared to wild-type TP53."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by a Tukey post-hoc test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels within 80-120% of baseline.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels below 80% or above 120% of baseline.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}